Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis

OBJECTIVE: To evaluate the effectiveness and safety of dipeptidyl peptidase-4 (DPP-4) inhibitors versus intermediate-acting insulin for adults with type 2 diabetes mellitus (T2DM) and poor glycaemic control despite treatment with two oral agents. SETTING: Studies were multicentre and multinational....

Descripción completa

Detalles Bibliográficos
Autores principales: Tricco, Andrea C, Antony, Jesmin, Khan, Paul A, Ghassemi, Marco, Hamid, Jemila S, Ashoor, Huda, Blondal, Erik, Soobiah, Charlene, Yu, Catherine H, Hutton, Brian, Hemmelgarn, Brenda R, Moher, David, Majumdar, Sumit R, Straus, Sharon E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275675/
https://www.ncbi.nlm.nih.gov/pubmed/25537781
http://dx.doi.org/10.1136/bmjopen-2014-005752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275675/
https://www.ncbi.nlm.nih.gov/pubmed/25537781
http://dx.doi.org/10.1136/bmjopen-2014-005752

Ejemplares similares